Romania’s Cantacuzino Banned From Marketing Vaccines

Romania’s National Medicine Agency (ANM) in February withdrew license for vaccine producer Cantacuzino Institute to market injectable medicines, including vaccines, as the institute is no longer in line with the EU good manufacturing practice regulations.

10 views

The announcement was made Tuesday by Cantacuzino Institute manager Radu Iordachel, during hearings in the Parliament health committee.

Iordachel said 450 employees will be laid off after the vaccine production line is closed, adding the National Medicine Agency sent the institute the notification stating the institute is forbidden to market injectable medicines on February 8.

If you liked this story, please follow MEDIAFAX.RO on FACEBOOK »

The content of mediafax.ro is for your information only. Republishing or using this content is forbidden without express consent of MEDIAFAX. For this consent, please ask for it by mail at vanzari@mediafax.ro.